MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0028464
Chiron Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4 Cr
▲ 11% YoY
Net profit · FY 2024
₹8.74 Lakh
Net margin 2.2%
EBITDA · FY 2024
₹16.79 Lakh
EBITDA margin 4.2%
Authorised capital
₹65 Lakh
Registered with MCA
Paid-up capital
₹65 Lakh
Issued & subscribed
Open charges
₹41.99 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
25
Provident fund records
About Chiron Pharmaceuticals Private Limited
Data last updated:
Chiron Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2007PTC065447. Its GSTIN is 37AADCC8452A1ZW (Andhra Pradesh).
The company has an authorised share capital of ₹65 Lakh and a paid-up capital of ₹65 Lakh. It is led by directors including Vijaya Raghavan Vinjamuri and Krishnareddy Gopavarapu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.4 3rd Street Ram Nagar North Madipakkam, Chennai, Tamil Nadu, India – 600091.
As per the financials filed for FY 2024, the company reported a revenue of ₹4 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹8.74 Lakh (net margin 2.2%) and EBITDA of ₹16.79 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 4% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹41.99 Lakh on record.
Chiron Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0028464). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chironpharma.com.
Company details
CIN U24230TN2007PTC065447
Registration Number 065447
Incorporation Date 21 November 2007
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0028464
Key People
Vijaya Raghavan Vinjamuri Director Krishnareddy Gopavarapu Director Kannareddy Naveenkumar Reddy Director Recognitions & Rankings of Chiron Pharmaceuticals
Contact details
Chiron Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is chironpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.4 3rd Street Ram Nagar North Madipakkam, Chennai, Tamil Nadu, India – 600091
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Chiron Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Chiron Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Chiron Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Chiron Pharmaceuticals Private Limited, buy the company report.
Financials of Chiron Pharmaceuticals Private Limited
FY 2025 filings availableChiron Pharmaceuticals Private Limited reported revenue of ₹4 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹4 Cr ▲ 11%
Net profit · FY 2024
₹8.74 Lakh margin 2.2%
EBITDA · FY 2024
₹16.79 Lakh margin 4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 17%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 74%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 11% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chiron Pharmaceuticals Private Limited, buy the company report.
Board of directors of Chiron Pharmaceuticals Private Limited
Chiron Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijaya Raghavan Vinjamuri | Director | 21 Nov 2007 | 18 Years 11 Months | Current |
| Krishnareddy Gopavarapu | Director | 23 Sep 2009 | 17 Years 1 Months | Current |
| Kannareddy Naveenkumar Reddy | Director | 19 Oct 2011 | 15 Years 0 Months | Current |
Peer comparison
Chiron Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ezyspit Solutions Private Limited | ₹4.02 Cr (FY 2022) | 1429.0% | Maratha Hotel Nagpur, Maharashtra, India | |||
| Biomodex Pharmaceuticals Private Limited | ₹4.02 Cr (FY 2025) | 39.0% | New Delhi, Delhi, India | |||
| Algen Remedies Private Limited | ₹4.01 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Verlen Labs Private Limited | ₹4.01 Cr (FY 2024) | -18.0% | Secunderabad, Telangana, India | |||
| Amraph India Private Limited | ₹4.01 Cr (FY 2024) | 31.0% | New Delhi, Delhi, India | |||
| Chiron Pharmaceuticals Private Limitedthis company | ₹4 Cr (FY 2024) | ₹8.74 Lakh | 2.2% | 11.0% | 25 | Chennai, Tamil Nadu, India |
| Cure Quick Remedies Private Limited | ₹4 Cr (FY 2025) | -42.0% | Haryana, India | |||
| Astraazin Pharmaceuticals Private Limited | ₹4 Cr (FY 2025) | -6.0% | New Delhi, Delhi, India | |||
| Aslan Healthcare Private Limited | ₹3.99 Cr (FY 2024) | -7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Chiron Pharmaceuticals Private Limited, buy the company report.
Auditor
Chiron Pharmaceuticals Private Limited is audited by S SARAVANAN & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S SARAVANAN & ASSOCIATES | FY 2022 | 011086S |
Shareholding
The shareholding of Chiron Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chiron Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹41.99 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Aug 2018 | 100206689 | Hdfc Bank Limited | ₹41.99 Lakh | Open |
To see the full charge records of Chiron Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Chiron Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chiron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Chiron Pharmaceuticals Private Limited has a workforce of 25 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
25
Active EPFO establishments
1
Employee growth
-19.35%
GST
Chiron Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCC8452A1ZW | Andhra Pradesh | Active | 08 Jul 2017 |
To see the full GST registrations and return filing status of Chiron Pharmaceuticals Private Limited, buy the company report.
Recent activity
Chiron Pharmaceuticals Private Limited has 5 board changes on record since 2007: 3 appointments and 2 cessations. The latest: Kannareddy Naveenkumar Reddy ceased to be Additional Director on 30 Sep 2012.
AGM
Chiron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Chiron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Hdfc Bank Limited of Rs. 41.99 Lakh registered on 29 Aug 2018 with Charge ID 100206689 was modified on 22 Sep 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 41.99 Lakh with Charge ID 100206689 was registered on 29 Aug 2018.
Ceased
Kannareddy Naveenkumar Reddy ceased to be Additional Director.
Appointed
Kannareddy Naveenkumar Reddy was appointed as Director.
Appointed
Krishnareddy Gopavarapu was appointed as Director.
Ceased
Vatturi Venkata Krishna Prasad ceased to be Director.
Appointed
Vijaya Raghavan Vinjamuri was appointed as Director.
Incorporation
21 Nov 2007
Chiron Pharmaceuticals Private Limited was registered on 21 Nov 2007 with Roc Chennai & aged 18 years 11 months as per MCA records.
Frequently asked questions
Chiron Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 November 2007 (19+ years old) and is registered under CIN U24230TN2007PTC065447.
Chiron Pharmaceuticals has 3 current directors:
- Vijaya Raghavan Vinjamuri - Director
- Krishnareddy Gopavarapu - Director
- Kannareddy Naveenkumar Reddy - Director
The latest financial statements of Chiron Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Chiron Pharmaceuticals is 37AADCC8452A1ZW, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Chiron Pharmaceuticals is U24230TN2007PTC065447. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chiron Pharmaceuticals was incorporated on 21 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Chiron Pharmaceuticals by revenue are Ezyspit Solutions Private Limited, Biomodex Pharmaceuticals Private Limited, Algen Remedies Private Limited, Verlen Labs Private Limited, Amraph India Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kannareddy Naveenkumar Reddy ceased to be Additional Director on 30 Sep 2012. Kannareddy Naveenkumar Reddy was appointed as Director on 19 Oct 2011. Krishnareddy Gopavarapu was appointed as Director on 23 Sep 2009. Chiron Pharmaceuticals has 5 board changes on record in total.
Yes, Chiron Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0028464).
Chiron Pharmaceuticals can be reached through the website chironpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Chiron Pharmaceuticals is at No.4 3rd Street Ram Nagar North Madipakkam, Chennai, Tamil Nadu, India – 600091.